Literature DB >> 1351926

Pharmacological characterization and autoradiographic localization of histamine H2 receptors in human brain identified with [125I]iodoaminopotentidine.

E Traiffort1, H Pollard, J Moreau, M Ruat, J C Schwartz, M I Martinez-Mir, J M Palacios.   

Abstract

125I-Aminopotentidine (125I-APT), a reversible probe of high specific radioactivity and high affinity and selectivity for the H2 receptor, was used to characterize and localize this histamine receptor subtype in human brain samples obtained at autopsy. On membranes of human caudate nucleus, specific 125I-APT binding at equilibrium revealed a single component, with a dissociation constant of 0.3 nM and maximal capacity of about 100 fmol/mg of protein. At 0.2 nM, 125I-APT specific binding, as defined with tiotidine, an H2-receptor antagonist chemically unrelated to iodoaminopotentidine, represented 40-50% of the total. Specific 125I-APT binding was inhibited by a series of typical H2-receptor antagonists that displayed apparent dissociation constants closely similar to corresponding values at the reference biological system, i.e., guinea pig atrium. This indicates that the pharmacology of the H2 receptor is the same in the human brain as on this reference system. However, histamine was about 10-fold more potent in inhibiting 125I-APT binding to membranes of human brain than of guinea pig brain. 125I-APT binding was also inhibited by amitriptyline and mianserin, two antidepressant drugs, in micromolar concentrations corresponding to effective plasma concentrations of treated patients. The distribution of H2 receptors was established autoradiographically with 125I-APT on a series of coronal sections of human brain after assessing the pharmacological specificity of the labeling. The highest density of 125I-APT sites was found in the basal ganglia, various parts of the limbic system, e.g., hippocampus or amygdaloid complex, and the cerebral cortex. H2 receptors displayed a laminar distribution in cerebral cortex and hippocampal formation. A low density of sites was found in cerebellum as well as in hypothalamus, the brain area where all the perikarya and the largest number of axons of histaminergic neurons are found. The widespread distribution of H2 receptors in the human brain is consistent with the alleged modulatory role of histamine mediated by this subtype of receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351926     DOI: 10.1111/j.1471-4159.1992.tb08903.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

Review 1.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

2.  Interactions of recombinant human histamine H₁R, H₂R, H₃R, and H₄R receptors with 34 antidepressants and antipsychotics.

Authors:  Heidrun Appl; Tobias Holzammer; Stefan Dove; Ekkehard Haen; Andrea Strasser; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-10-28       Impact factor: 3.000

3.  Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain.

Authors:  Gabriele Cenni; Patrizio Blandina; Ken Mackie; Daniele Nosi; Lucia Formigli; Patrizia Giannoni; Chiara Ballini; Laura Della Corte; Pier Francesco Mannaioni; M Beatrice Passani
Journal:  Eur J Neurosci       Date:  2006-09       Impact factor: 3.386

Review 4.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

5.  Cardiac and gastric effects of histamine H2 receptor antagonists: no evidence for a correlation between lipophilicity and receptor affinity.

Authors:  G Coruzzi; M Adami; C Pozzoli; F Giorgi; G Bertaccini
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  Modulation of genioglossus muscle activity across sleep-wake states by histamine at the hypoglossal motor pool.

Authors:  Timothy Bastedo; Erin Chan; Eileen Park; Hattie Liu; Richard L Horner
Journal:  Sleep       Date:  2009-10       Impact factor: 5.849

7.  Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells.

Authors:  R Leurs; M J Smit; W M Menge; H Timmerman
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

8.  Phase 1A safety assessment of intravenous amitriptyline.

Authors:  Peter Fridrich; Hans Peter Colvin; Anthony Zizza; Ajay D Wasan; Jean Lukanich; Philipp Lirk; Alois Saria; Gerald Zernig; Thomas Hamp; Peter Gerner
Journal:  J Pain       Date:  2007-05-23       Impact factor: 5.820

9.  Histamine H₂ receptor signaling × environment interactions determine susceptibility to experimental allergic encephalomyelitis.

Authors:  Naresha Saligrama; Laure K Case; Dimitry N Krementsov; Cory Teuscher
Journal:  FASEB J       Date:  2013-12-26       Impact factor: 5.191

Review 10.  Topical Treatments for Localized Neuropathic Pain.

Authors:  Roberto Casale; Z Symeonidou; M Bartolo
Journal:  Curr Pain Headache Rep       Date:  2017-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.